Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine.
The global Purixan market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Purixan volume and value at global level, regional level and company level. From a global perspective, this report represents overall Purixan market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Purixan in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Purixan manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Segment by Regions
Segment by Type
Segment by Application